Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine for Pain in Acute Burn Injuries (RELIEVE)
NCT05465226Phase 4Completed
- Sponsor
- University of Tennessee
- Start
- Apr 2023
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of oliceridine in acute pain (2 arms), sponsored by University of Tennessee. Primary endpoint: Change in pain scores after initiation of oliceridine up to 7 days. Started Apr 2023; status: completed.
02
Drugs
oliceridine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT05465226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05465226.